Skip to main content

Andrew Fedder, Esq.

General Counsel

Mr. Fedder joined Scorpion Therapeutics in September 2021 with over a decade of legal experience. Prior to joining Scorpion Therapeutics, Mr. Fedder worked at Bristol-Myers Squibb Company (“Bristol-Myers”) in increasing…

Mr. Fedder joined Scorpion Therapeutics in September 2021 with over a decade of legal experience. Prior to joining Scorpion Therapeutics, Mr. Fedder worked at Bristol-Myers Squibb Company (“Bristol-Myers”) in increasing roles of responsibility, most recently acting as Assistant General Counsel for Corporate and Business Development between May 2021 and September 2021 and, previously, as Senior Corporate Counsel for the company’s Mergers & Acquisitions team, from April 2019 to May 2021. Prior to his time at Bristol-Myers, Mr. Fedder was an associate at international law firms Willkie Farr & Gallagher LLP from November 2013 to September 2016 and Wilson Sonsini Goodrich & Rosati, P.C. between January 2011 and October 2013.

Mr. Fedder holds a J.D. from Emory University School of Law and a B.A. in Economics from Johns Hopkins University.